Cardiol Therapeutics Inc. (CRDL.TO)
CAD 1.96
(0.51%)
CAD 1.96
(0.51%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -27.87 Million CAD | 40.96% |
| 2022 | -30.71 Million CAD | -10.75% |
| 2021 | -38.44 Million CAD | -122.08% |
| 2020 | -20.41 Million CAD | -51.69% |
| 2019 | -13.53 Million CAD | -84.04% |
| 2018 | -15.13 Million CAD | -375.2% |
| 2017 | -1.54 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -7.67 Million CAD | 8.14% |
| 2024 Q1 | -8.34 Million CAD | -10.43% |
| 2023 Q4 | -7.96 Million CAD | 7.97% |
| 2023 FY | - CAD | 41.07% |
| 2023 Q3 | -8.65 Million CAD | -89.29% |
| 2023 Q2 | -4.57 Million CAD | 41.99% |
| 2023 Q1 | -7.87 Million CAD | 21.47% |
| 2022 Q2 | -11.72 Million CAD | -11.75% |
| 2022 Q1 | -10.49 Million CAD | 47.08% |
| 2022 FY | - CAD | -10.75% |
| 2022 Q4 | -10.03 Million CAD | 43.83% |
| 2022 Q3 | -17.86 Million CAD | -52.26% |
| 2021 Q1 | -8.97 Million CAD | 5.89% |
| 2021 Q2 | -6.2 Million CAD | 30.89% |
| 2021 Q3 | -10.23 Million CAD | -64.89% |
| 2021 Q4 | -19.83 Million CAD | -93.84% |
| 2021 FY | - CAD | -122.08% |
| 2020 FY | - CAD | -51.69% |
| 2020 Q4 | -9.54 Million CAD | -120.34% |
| 2020 Q3 | -4.33 Million CAD | -23.27% |
| 2020 Q2 | -3.51 Million CAD | -17.34% |
| 2020 Q1 | -2.99 Million CAD | -0.41% |
| 2019 Q1 | -3.39 Million CAD | -6.54% |
| 2019 FY | - CAD | -84.04% |
| 2019 Q2 | -3.56 Million CAD | -5.01% |
| 2019 Q4 | -2.98 Million CAD | 14.41% |
| 2019 Q3 | -3.48 Million CAD | 2.42% |
| 2018 Q4 | -3.19 Million CAD | -34.46% |
| 2018 Q1 | -510.47 Thousand CAD | 6.07% |
| 2018 FY | - CAD | -375.2% |
| 2018 Q2 | -1.22 Million CAD | -140.03% |
| 2018 Q3 | -2.37 Million CAD | -93.64% |
| 2017 Q4 | -543.48 Thousand CAD | -10.6% |
| 2017 Q2 | -393.12 Thousand CAD | 0.0% |
| 2017 Q3 | -491.4 Thousand CAD | -25.0% |
| 2017 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aurora Cannabis Inc. | 20.47 Million CAD | 236.172% |
| Avicanna Inc. | -7.35 Million CAD | -279.037% |
| Avant Brands Inc. | 4.83 Million CAD | 676.508% |
| Crescita Therapeutics Inc. | 45 Thousand CAD | 62055.42% |
| Knight Therapeutics Inc. | 40.89 Million CAD | 168.171% |
| MediPharm Labs Corp. | -10.47 Million CAD | -166.081% |
| OrganiGram Holdings Inc. | -207.61 Million CAD | 86.572% |
| Canopy Growth Corporation | -312.82 Million CAD | 91.088% |
| Willow Biosciences Inc. | -11.06 Million CAD | -152.056% |
| Auxly Cannabis Group Inc. | -10.82 Million CAD | -157.551% |